Sale by Russo Thomas Joseph of 3066 shares of Icosavax

ICVXDelisted Stock  USD 9.02  0.12  1.31%   
Slightly above 62% of Icosavax's investor base is looking to short. The analysis of current outlook of investing in Icosavax suggests that many traders are alarmed regarding Icosavax's prospects. Icosavax's investing sentiment can be driven by a variety of factors including economic data, Icosavax's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Icosavax Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
Icosavax insider trading alert for sale of common stock by Russo Thomas Joseph, Chief Financial Officer, on 1st of August 2023. This event was filed by Icosavax Inc with SEC on 2023-08-01. Statement of changes in beneficial ownership - SEC Form 4

Icosavax Fundamental Analysis

We analyze Icosavax's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icosavax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icosavax based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Icosavax is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Icosavax Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icosavax stock to make a market-neutral strategy. Peer analysis of Icosavax could also be used in its relative valuation, which is a method of valuing Icosavax by comparing valuation metrics with similar companies.

Peers

Icosavax Related Equities

XFORX4 Pharmaceuticals   10.87   
0%
100.0%
HEPAHepion Pharmaceuticals   4.44   
0%
40.0%
AMLXAmylyx Pharmaceuticals   2.86   
0%
26.0%
ABOSAcumen Pharmaceuticals   2.48   
0%
22.0%
PDSBPDS Biotechnology   1.40   
0%
12.0%
DAWNDay One   1.13   
0%
10.0%
HOOKHookipa Pharma   0.52   
0%
4.0%
ELDNEledon Pharmaceuticals   0.25   
2.0%
0%
IMMXImmix Biopharma   0.97   
8.0%
0%
MREOMereo BioPharma   1.38   
12.0%
0%
INZYInozyme Pharma   1.45   
13.0%
0%
TERNTerns Pharmaceuticals   1.56   
14.0%
0%
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Icosavax Stock

If you are still planning to invest in Icosavax check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Icosavax's history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital